Related Experiment Video
Updated: Jul 20, 2025

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
[Overexpression of MKRN2 Inhibits the Growth of Ovarian Cancer Cells]
1Department of Obstetrics and Gynecology, Dushu Lake Hospital affiliated to Soochow University, Soochow University, Suzhou, China.
Abstract:
Ovarian cancer has a high mortality with low five-year survival rates. The role of the E3 ligase Makorin ring finger protein 2 (MKRN2) in ovarian cancer is unknown. This study investigated the impact of MKRN2 on the growth of ovarian cancer. MKRN2 expression in ovarian cancer tissue was analyzed by immunohistochemistry. Overexpression of MKRN2 was induced in two ovarian cancer cell lines (SKOV3 and CAOV3) by lentivirus transfection, and expression levels were verified by western blotting. Proliferation and growth were determined by CCK-8 and colony formation assays, while migration was examined using transwell assays and apoptosis by flow cytometry. Xenograft tumors of transfected SKOV3 cells were established in mice, and immunohistochemistry and TUNEL assays measured MKRN2 levels and apoptosis in tumor cells. Reduced levels of MKRN2 in cancerous tissue relative to non-cancerous ovarian tissues. Lentiviral-based MKRN2 overexpression in SKOV3 and CAOV3 cells reduced tumor-associated behavior while inducing apoptosis in vitro. In xenograft tumors, MKRN2 overexpression inhibited ovarian cancer growth and increased apoptosis in vivo. These findings imply the MKRN2 involvement in ovarian carcinogenesis and suggest its potential for treating the disease.
Insights
Makorin ring finger protein 2 (MKRN2) was found to be reduced in ovarian cancer tissues. Overexpressing MKRN2 suppressed ovarian cancer cell growth, migration, and induced apoptosis, suggesting its therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Context:
- Ovarian cancer presents a significant global health challenge with poor prognoses.
- The specific function of E3 ligase Makorin ring finger protein 2 (MKRN2) in ovarian cancer remains largely unexplored.
- Understanding novel molecular players is crucial for developing effective ovarian cancer therapies.
Purpose:
- To investigate the role and impact of MKRN2 expression on ovarian cancer progression.
- To analyze MKRN2 expression levels in ovarian cancer tissues and cell lines.
- To evaluate the effects of MKRN2 overexpression on ovarian cancer cell behavior in vitro and in vivo.
Summary:
- MKRN2 expression was significantly lower in ovarian cancer tissues compared to normal tissues.
- Lentiviral-mediated overexpression of MKRN2 in SKOV3 and CAOV3 ovarian cancer cell lines reduced proliferation, migration, and induced apoptosis.
- In vivo studies using xenograft models confirmed that MKRN2 overexpression inhibits tumor growth and enhances apoptosis.
Impact:
- Findings suggest MKRN2 acts as a tumor suppressor in ovarian cancer.
- MKRN2's role in ovarian carcinogenesis is elucidated, highlighting its potential as a therapeutic target.
- This research opens avenues for novel treatment strategies targeting MKRN2 in ovarian cancer management.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
MicroRNAs
Abnormal Proliferation
Inhibition of Cdk Activity
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

